E. A. Zasim

E. A. Zasim

Auto-generated profile, based on publicly available information

E. A. Zasim

Republican scientific and practical center of pediatric surgery

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
TVT. G. Vaikhanskaya
T. G. Vaikhanskaya
LSLarysa Sivitskaya
Larysa Sivitskaya
TKT. V. Kurushko
T. V. Kurushko
DED. P. Ermakovich
D. P. Ermakovich
EZE. V. Zasim
E. V. Zasim
NDN. G. Danilenko
N. G. Danilenko
Синдром Карвахаль: краткий обзор и клинический случай кардиомиопатии, ассоциированной с компаунд гетерозиготными мутациями гена десмоплакина

22 November 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
NCN. N. Chakova
N. N. Chakova
SKS. M. Komissarova
S. M. Komissarova
EZE. A. Zasim
E. A. Zasim
TDT. V. Dolmatovich
T. V. Dolmatovich
ERE. S. Rebeko
E. S. Rebeko
MDM. V. Dudko
M. V. Dudko
Aim. To determine the spectrum of mutations in the genes responsible for the long QT syndrome (LQTS) and study their phenotypic manifestations in patients with LQTS in different age groups.Materials and methods. The study included 35 unrelated probands with a clinical diagnosis of LQTS: 23 adults (8 men) and 12 children (9 boys). There were following clinical features: syncope — 54%, positive family history for SCD — 29%, implanted cardioverter defibrillator (ICD) — 46%. All participants underwent 12-lead electrocardiography (ECG), 24-hour Holter monitoring, genealogical analysis, echocardiography and cardiac MRI. The genetic study was performed by nextgeneration sequencing (NGS) using the MiSeq system (Illumina). The quantitative comparison of two unrelated groups was carried out using the nonparametric MannWhitney U-test. The differences were considered significant at p520 ms). All patients with LQT2 (4 children, 4 adults) had QTc >500 ms. At the same time, 2 children and 3 women had an ICD. LQT3 was diagnosed only in the children subgroup (2 boys, with QTc of 510 ms and QTc of 610 ms); one of them died suddenly despite beta-blocker therapy. Four adult patients, carriers of class III pathogenicity variants, had QTc <500 ms and delayed disease manifestation (after 30 years). Three of them had episodes of clinical death with subsequent resuscitation and implantation of cardioverter defibrillator.Conclusion. The average diagnostic efficiency of mutation identification using NGS in patients with clinically manifest LQTS was 66%. At the same time, mutations were more common in the children’s group. In genotype-positive probands, the risk of adverse outcomes correlated with sex, age and the genetic variant of disease. The greatest number of adverse outcomes was observed in carriers of mutations in both KCNH2 (LQT2) and SCN5A (LQT3) genes. Variants with unknown clinical significance were identified in 4 probands (11%), which potentially allowed to confirm the diagnosis after functional tests.